502 SAMHSA-listed treatment centers in Kentucky. Free, confidential help available 24/7.
Browse 502 verified drug and alcohol treatment facilities in Kentucky. Each listing is sourced from federal databases and verified for accuracy. Use the information below to compare programs, verify insurance acceptance, and find the right facility for your needs.
Need help choosing? Call for free, confidential guidance from a treatment specialist.
The overdose death rate in Kentucky stands at 54.7/100,000 in CDC's latest data — above the US average (32.6). Available treatment in the state covers the full ASAM continuum: medically supervised withdrawal management, 28–90-day residential stays, PHP and IOP step-down programs, and ongoing outpatient counseling.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
Recovery does not end at the discharge ceremony. Kentucky's data, like national data, shows that the first 90 days post-treatment carry the highest relapse risk — and structured aftercare during that window is the single largest mitigator.
Step down from PHP/IOP to weekly individual therapy + monthly med management. Most plans cover 6+ months.
Sober living homes range from highly structured residences to lightly-supervised group homes. In Kentucky, NARR-certified ones meet a national standard; uncertified ones vary widely.
AA, NA, SMART Recovery, Celebrate Recovery, Refuge Recovery, LifeRing, Women for Sobriety.
Buprenorphine, methadone, or naltrexone should continue long-term for opioid-use disorder.
Lived-experience navigators with state certification. Particularly effective for newcomers to recovery navigating employment, housing, and court-system involvement.
Naloxone (Narcan) is available without prescription at most Kentucky pharmacies under standing orders. Family training is the second piece — kit alone is not enough.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
Treatment varies in intensity and structure but combines several evidence-based components. Knowing what is coming reduces first-week anxiety and improves engagement.
Evidence-based for alcohol, cannabis, cocaine, and methamphetamine use disorders. Typically 12–24 sessions; manualized protocols available for clinicians.
Motivational Interviewing engages the person's own reasons to change rather than imposing them. Most effective in early-treatment ambivalence.
MAT reduces overdose mortality by 50%+ in opioid-use disorder. Buprenorphine, methadone, and extended-release naltrexone are the three FDA-approved options.
DBT teaches four skill sets: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness. All apply to addiction recovery.
About half of people entering addiction treatment also meet criteria for a trauma-related diagnosis. Specific therapies (EMDR, CPT, Seeking Safety) address both.
Twelve-step facilitation as a clinical approach is evidence-based; AA/NA participation itself is one of multiple aftercare options.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in Kentucky must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · Kentucky Medicaid · Tricare (military) · VA Community Care
In Kentucky, Medicaid is administered as Kentucky Medicaid. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
Family-systems work used to be optional in addiction treatment; today, it is built into the curriculum at most Kentucky mid-size and larger facilities. The retention and 1-year-sober data justifies the time investment.
For most Kentucky residents, the admission pipeline runs: free confidential phone consultation → insurance verification (24 hours) → ASAM clinical assessment → logistics planning → arrival day. Same-day starts are available at facilities offering medically supervised detox.
Uninsured residents of Kentucky have access to seven distinct pathways to treatment, from full-coverage Medicaid (for those who qualify) to sliding-scale outpatient at federally qualified health centers (FQHCs).
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
Targeted programming is now table stakes at mid-size Kentucky facilities — generic mixed-group programming is no longer the default for veterans, adolescents, or dual-diagnosis patients.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
This section covers state-level context for addiction treatment in Kentucky: how the clinical continuum is structured, what federal resources are available, how insurance works in practice, and what evidence-based approaches apply to different substances and populations. The goal is to equip you to navigate Kentucky treatment options effectively, whether you're researching for yourself or a family member.
Suicide risk in addiction is elevated and warrants direct attention. Kentucky residents with active suicidal ideation should contact 988 immediately, present to an emergency department, or call a mental-health crisis mobile team if available locally. Family members concerned about a loved one's suicide risk can also use 988 for guidance; operators are trained in third-party crisis situations. Means restriction — removing or locking up firearms, medications, and other lethal means during a crisis — reduces completed suicide.
Telehealth has expanded substance-use treatment access in Kentucky since federal and state policy changes during the COVID emergency made remote care reimbursable at parity with in-person. Outpatient counseling, MAT induction and maintenance (now permitted via telehealth for buprenorphine), and group therapy can all be delivered remotely. Telehealth is especially impactful for rural Kentucky residents and patients who cannot easily travel due to work, caregiving, or disability. Most major insurers cover telehealth addiction services at the same rate as in-person.
Self-pay options for Kentucky addiction treatment include facility-direct payment plans, medical credit lines (e.g., CareCredit), 401(k) hardship withdrawals, family financing, and sliding-scale community-based programs. Some facilities offer scholarships or reduced rates for patients without insurance. Federally Qualified Health Centers in Kentucky provide outpatient addiction services on sliding-scale terms based on income. Religious-affiliated programs often have separate financial-assistance pathways.
The Kentucky addiction treatment continuum spans pre-treatment screening through long-term recovery support. Initial screening typically uses validated instruments — AUDIT for alcohol, DAST for drugs, and ASAM Continuum for level-of-care determination. Treatment intensity drops as patients stabilize, but engagement with recovery support typically continues for at least 12 months post-treatment, reflecting addiction's status as a chronic condition requiring ongoing management.
Federal data on Kentucky substance use comes from multiple sources: CDC WONDER provides drug-overdose mortality statistics; the National Survey on Drug Use and Health (NSDUH) tracks treatment access and substance-use prevalence; SAMHSA's TEDS (Treatment Episode Data Set) captures admissions and discharges; and the State Unintentional Drug Overdose Reporting System (SUDORS) tracks overdose deaths in detail. These datasets are public and inform both treatment policy and patient resource navigation.
Sober living environments (SLEs) in Kentucky bridge residential treatment and full independent living. SLEs vary widely in quality and structure; the National Alliance for Recovery Residences (NARR) provides a quality-standards framework with four certification levels (peer-run to fully clinical). Reputable Kentucky SLEs require drug testing, mutual-support meeting attendance, and progressive responsibility (employment, household contribution, recovery-plan accountability). Length of stay is typically 3-12 months, longer for patients with severe addiction histories or unstable home environments.